Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine

• Jason S. Richardson ,

  Contributed equally to this work with: Jason S. Richardson, Michel K. Yao

  Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• Michel K. Yao ,

  Contributed equally to this work with: Jason S. Richardson, Michel K. Yao

  Affiliation Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• Kaylie N. Tran,

  Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• Maria A. Croyle,

  Affiliations Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, Texas, United States of America, Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, Texas, United States of America

  ⨯
• James E. Strong,

  Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• Heinz Feldmann,

  Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯
• Gary P. Kobinger

  * E-mail: gary_kobinger@phac-aspc.gc.ca

  Affiliations Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

  ⨯